x

Suche klinische Studie

* (*) Felder müssen ausgefüllt werden

10 Ergebnis(se)

Rekrutierende Studie = Rekrutierende Studie; Fortlaufende Studie = Fortlaufende Studie; Förderung durch ein IRDiRC-Mitglied = ; ERN-Mitglied =

Nationale klinische Studie(n)

VEREINIGTES KONIGREICH

Greater London
LONDON

CMT-TRAUK: Randomised double blind placebo controlled trial of long term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (Phase III) (Completed)
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

VEREINIGTES KONIGREICH

Greater London
LONDON

PADIMAC: Phase II study of Bortezomib, Adriamycin and Dexamethasone (PAD) therapy for previously untreated patients with multiple myeloma: Impact of minimal residual disease (MRD) in patients with deferred ASCT - UK
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

VEREINIGTES KONIGREICH

Greater London
LONDON

Bortezomib Consolidation Trial: A Phase II study of bortezomib consolidation after high dose therapy and autologous stem cell transplantation for multiple myeloma - UK
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

VEREINIGTES KONIGREICH

Greater London
LONDON

Fortlaufende StudieAn Open-Label, Multicenter, Extension Study of AG-348 in Adult Subjects With Pyruvate Kinase Deficiency Previously Enrolled in AG-348 Studies-GB
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

VEREINIGTES KONIGREICH

Greater London
LONDON

Fortlaufende StudieFörderung durch ein IRDiRC-MitgliedPhase II Study of Arimoclomol for the Treatment of Sporadic Inclusion Body Myositis (IBM) - GB
UCL Institute of Neurology, University College London,
Clinical Neurosciences

VEREINIGTES KONIGREICH

Greater London
LONDON

VEREINIGTES KONIGREICH

Greater London
LONDON

Rekrutierende StudieFortlaufende StudieCOBALT: Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation
University College London Hospitals NHS Foundation Trust
Cancer Division

VEREINIGTES KONIGREICH

Greater London
LONDON